Back to Search
Start Over
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review.
- Source :
-
Journal of Intensive Care . 2/8/2023, Vol. 11 Issue 1, p1-9. 9p. - Publication Year :
- 2023
-
Abstract
- A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of ventilator-induced lung injury and provide lung rest while awaiting recovery. The mortality of COVID-19-related ARDS was variously reassessed during the pandemic. Veno-venous (VV) ECMO was the default choice to manage refractory respiratory failure; however, with concomitant severe right ventricular dysfunction, venoarterial (VA) ECMO or mechanical right ventricular assist devices with extracorporeal gas exchange (Oxy-RVAD) were also considered. ECMO has also been used to manage special populations such as pregnant women, pediatric patients affected by severe forms of COVID-19, and, in cases with persistent and seemingly irreversible respiratory failure, as a bridge to successful lung transplantation. In this narrative review, we outline and summarize the most recent evidence that has emerged on ECMO use in different patient populations with COVID-19-related ARDS. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20520492
- Volume :
- 11
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Intensive Care
- Publication Type :
- Academic Journal
- Accession number :
- 161822305
- Full Text :
- https://doi.org/10.1186/s40560-023-00654-7